SEC Form 4 · accession 0001209191-18-042483
MARVELL TECHNOLOGY GROUP LTD · MRVL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Muhammad Raghib Hussain
Officer — EVP Chief Strategy Officer
Period of report
Jul 6, 2018
Accepted (ET)
Jul 12, 2018 · 5:42 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001058057
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common sharesF1 | Jul 6, 2018 | A | 497,578 | — | A | 497,578 | D | |
| Common sharesF2,F3 | Jul 6, 2018 | A | 78,325 | — | A | 575,903 | I | By family trusts |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy)F4 | $9.33 | Jul 6, 2018 | A | 40,339 | A | Jul 6, 2018 | Mar 22, 2020 | Common shares | 40,339 | 40,339 | D |
| Stock option (right to buy)F4 | $9.38 | Jul 6, 2018 | A | 100,848 | A | Jul 6, 2018 | Feb 7, 2021 | Common shares | 100,848 | 100,848 | D |
| Stock option (right to buy)F4,F5 | $15.58 | Jul 6, 2018 | A | 51,981 | A | — | Feb 16, 2022 | Common shares | 51,981 | 51,981 | D |
| Stock option (right to buy)F4,F6 | $12.12 | Jul 6, 2018 | A | 145,952 | A | — | Feb 11, 2023 | Common shares | 145,952 | 145,952 | D |
| Stock option (right to buy)F4,F7 | $16.31 | Jul 6, 2018 | A | 116,024 | A | — | Feb 10, 2024 | Common shares | 116,024 | 116,024 | D |
| Restricted stock unitsF9,F11,F8,F10 | — | Jul 6, 2018 | A | 24,909 | A | — | — | Common shares | 24,909 | 24,909 | D |
| Restricted stock unitsF12,F11,F8,F10 | — | Jul 6, 2018 | A | 37,773 | A | — | — | Common shares | 37,773 | 37,773 | D |
| Restricted stock unitsF13,F11,F8,F14 | — | Jul 6, 2018 | A | 25,990 | A | — | — | Common shares | 25,990 | 25,990 | D |
| Restricted stock unitsF15,F11,F8,F16 | — | Jul 6, 2018 | A | 82,211 | A | — | — | Common shares | 82,211 | 82,211 | D |
| Restricted stock unitsF17,F11,F8,F18 | — | Jul 6, 2018 | A | 99,202 | A | — | — | Common shares | 99,202 | 99,202 | D |
| Restricted stock unitsF19,F11,F8,F20 | — | Jul 6, 2018 | A | 130,151 | A | — | — | Common shares | 130,151 | 130,151 | D |
Explanation of responses
- F1Received in exchange for 228,698 shares of Cavium, Inc. common stock in connection with the merger (the "Merger") of Cavium, Inc. into Marvell Technology Group Ltd. ("Marvell"). On the effective date of the Merger, the Reporting Person received the reported common shares of Marvell.
- F10This award vests as to 100% of the shares on January 31, 2019.
- F11Received in the Merger in exchange for restricted stock units of Cavium, Inc.
- F12Received in exchange for 9,364 restricted stock units of Cavium, Inc. in connection with the Merger. On the effective date of the Merger, the Reporting Person received the reported restricted stock units of Marvell.
- F13Received in exchange for 6,443 restricted stock units of Cavium, Inc. in connection with the Merger. On the effective date of the Merger, the Reporting Person received the reported restricted stock units of Marvell.
- F14This award vests as to 100% of the shares on January 31, 2019.
- F15Received in exchange for 20,380 restricted stock units of Cavium, Inc. in connection with the Merger. On the effective date of the Merger, the Reporting Person received the reported restricted stock units of Marvell.
- F16This award vests as to 50% of the shares on each of January 31, 2019 and 2020.
- F17Received in exchange for 24,592 restricted stock units of Cavium, Inc. in connection with the Merger. On the effective date of the Merger, the Reporting Person received the reported restricted stock units of Marvell.
- F18This awards vests as to 1/3 of the shares on each of January 31, 2019, 2020 and 2021.
- F19Received in exchange for 32,264 restricted stock units of Cavium, Inc. in connection with the Merger. On the effective date of the Merger, the Reporting Person received the reported restricted stock units of Marvell.
- F2Received in exchange for 36,000 shares of Cavium, Inc. common stock in connection with the merger (the "Merger") of Cavium, Inc. into Marvell Technology Group Ltd. ("Marvell"). On the effective date of the Merger, the Reporting Person received the reported common shares of Marvell.
- F20This award vests as of 25% of the shares on each of January 31, 2019, 2020, 2021 and 2022.
- F3Held in trusts of which the Reporting Person is the trustee, for the benefit of members of his immediate family.
- F4Received in the Merger in exchange for employee stock options to acquire shares of Cavium, Inc. stock.
- F5Exercisable in equal monthly installments on the 16th of each month beginning 7/16/18 and ending 2/16/2019.
- F6Exercisable in equal monthly installments on the 11th of each month beginning 7/11/2018 and ending 2/11/2020.
- F7Exercisable in equal monthly installments on the 10th of each month beginning 7/10/2018 and ending 2/10/2021.
- F8Each restricted stock unit represents a contingent right to receive one Marvell Technology Group Ltd. ("Marvell") common share upon vesting.
- F9Received in exchange for 6,175 restricted stock units of Cavium, Inc. in connection with the Merger. On the effective date of the Merger, the Reporting Person received the reported restricted stock units of Marvell.